ZEVRA THERAPEUTICS, INC. (ZVRA)
Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
State Street to Speak at the Morgan Stanley U.S. Financials Conference
Principal Real Estate Income Fund Announces Notification of Sources of Distribution
QXO Announces Cash Tender Offers and Consent Solicitations for Any and All of TopBuild Corp.’s 4.125% Senior Notes due 2032 and 5.625% Senior Notes due 2034
PGIM Closed-End Funds Declare Distributions for June, July and August 2026
Blackstone Credit & Insurance Announces Extension of Reinvestment Period Ahead of May 31, 2027, Scheduled Dissolution Date for Blackstone Senior Floating Rate 2027 Term Fund
Essex Property Trust to Present at The 2026 Nareit REITweek Conference
KKR to Present at the Morgan Stanley US Financials Conference
Notice of Settlement of Shareholder Derivative Actions
Crescent Biopharma Announces Grants of Inducement Awards